Spine Fusion Implants and Bone-Healing Material for Disc Disease

Plain-English translation of NCT06704919 on ClinicalTrials.gov ↗ · Source last updated January 2026 · Translation generated August 2026 · How we translate trials

What is this trial?

This trial is studying how well two spine implants — Conduit cages and Fibergraft Bioactive Glass — work together when used during spine fusion surgery. These implants are designed to restore the spacing between vertebrae and help your spine bones fuse together. Researchers want to understand how well these implants help patients heal and whether they reduce the need for follow-up surgery.

While each of these implants has been used separately before, doctors don't yet have detailed information about how they work when used together. This study aims to fill that gap by carefully tracking how well patients recover and whether the bones fuse properly.

Do you qualify?

You likely qualify if…

you are 18 years or older
you have been diagnosed with degenerative disc disease, a herniated disc, or a ruptured disc in your neck or lower back
your spine problem affects one or two spine levels next to each other (not three or more)
your doctor has already recommended this specific surgery and these implants as your standard treatment
you have adequate bone density (a DEXA score of 2.0 or higher)

You likely don't qualify if…

you have a BMI over 40
you are a current smoker or quit smoking less than 6 weeks ago
you have had a previous failed spine fusion at the same location
your spine problem affects three or more levels
you have poor bone density (a DEXA score below 2.0)

What participation looks like

If you qualify, you will receive the spine fusion surgery as your doctor has recommended — the research part involves careful follow-up. You'll be monitored for two years with imaging scans and clinical assessments to track how well your spine heals, whether the bones fuse together properly, and whether you need any additional surgery. Your doctors will document your pain levels, function, and any complications.

AI-generated summary from trial data · Aug 24, 2026 · Not medical advice

Trial locations(1 site)

United States

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania